← Back to Discover
Sands Capital Ventures, LLC
Period ended Jun 30, 2026 · Latest filing Aug 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $613,546,175
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- ALAMAR BIOSCIENCES INC · COMMON STOCK · 010911105 · shares: $114,615,785
- NU HLDGS LTD · ORD SHS CL A · G6683N103 · shares: $94,788,559
- KLAVIYO INC · COM SER A · 49845K101 · shares: $59,315,005
- BETA BIONICS INC · COM · 08659B102 · shares: $58,105,034
- SPYGLASS PHARMA INC · COM SHS · 85220G109 · shares: $55,650,267
- INHIBIKASE THERAPEUTICS INC · COM NEW · 45719W205 · shares: $26,428,499
- DOORDASH INC · CL A · 25809K105 · shares: $23,539,016
- COUPANG INC · CL A · 22266T109 · shares: $23,090,184
- DATADOG INC · CL A COM · 23804L103 · shares: $21,050,366
- BIOAGE LABS INC · COM · 09077V100 · shares: $19,273,512
Reported holdings
24 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| ALAMAR BIOSCIENCES INC | COMMON STOCK | 010911105 | — | 4,230,926 shares | $114,615,785 |
| NU HLDGS LTD | ORD SHS CL A | G6683N103 | — | 7,094,952 shares | $94,788,559 |
| KLAVIYO INC | COM SER A | 49845K101 | — | 3,928,146 shares | $59,315,005 |
| BETA BIONICS INC | COM | 08659B102 | — | 3,708,043 shares | $58,105,034 |
| SPYGLASS PHARMA INC | COM SHS | 85220G109 | — | 2,500,012 shares | $55,650,267 |
| INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | — | 13,018,965 shares | $26,428,499 |
| DOORDASH INC | CL A | 25809K105 | — | 127,562 shares | $23,539,016 |
| COUPANG INC | CL A | 22266T109 | — | 1,329,314 shares | $23,090,184 |
| DATADOG INC | CL A COM | 23804L103 | — | 80,851 shares | $21,050,366 |
| BIOAGE LABS INC | COM | 09077V100 | — | 786,353 shares | $19,273,512 |
| 10X GENOMICS INC | CL A COM | 88025U109 | — | 481,770 shares | $18,471,062 |
| SAMSARA INC | COM CL A | 79589L106 | — | 515,658 shares | $16,722,789 |
| ODYSSEY THERAPEUTICS INC | COMMON STOCK | 67613T104 | — | 875,000 shares | $16,371,250 |
| TOAST INC | CL A | 888787108 | — | 364,879 shares | $10,150,934 |
| ACUMEN PHARMACEUTICALS INC | COM | 00509G209 | — | 3,720,105 shares | $9,932,680 |
| SERVICETITAN INC | SHS CL A | 81764X103 | — | 108,545 shares | $7,675,217 |
| CEREBRAS SYSTEMS INC | COM CL A | 15675D103 | — | 32,825 shares | $7,254,325 |
| SNOWFLAKE INC | COM SHS | 833445109 | — | 24,498 shares | $6,234,741 |
| MONDAY COM LTD | SHS | M7S64H106 | — | 81,982 shares | $5,934,677 |
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | — | 85,000 shares | $5,349,900 |
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | — | 724,873 shares | $4,936,385 |
| CANDEL THERAPEUTICS INC | COM | 137404109 | — | 405,837 shares | $4,180,121 |
| ACRIVON THERAPEUTICS INC | COMMON STOCK | 004890109 | — | 2,289,271 shares | $4,074,902 |
| FIGMA INC | CLASS A COM STK | 316841105 | — | 22,165 shares | $400,965 |